ArticleCancers2023

The Tumor Microenvironment in Classic Hodgkin's Lymphoma in Responder and No-Responder Patients to First Line ABVD Therapy.

Roberto Tamma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.